Research suggests that a lung-pancreatic cell transplant may be a safe and effective treatment for cystic fibrosis patients with cystic fibrosis-related diabetes. Other potential treatments, including mRNA therapies and CFTR modulators, are also being explored for their efficacy and safety in managing cystic fibrosis. The effectiveness of various treatments, such as Kaftrio and triple CFTR modulator therapy, is being studied and reviewed in clinical trials and real-world settings.